NCT05265052 2026-03-113D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain3D MedicinesPhase 2 Not yet recruiting177 enrolled
NCT07008703 2025-06-06Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer PainShenyang Sunshine Pharmaceutical Co., LTD.Phase 1/2 Recruiting132 enrolled